GCP
EXAS

Garda Capital Partners’s Exact Sciences EXAS Stock Holding History

Garda Capital Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,000
Closed -$888K – 450
2023
Q4 		$888K Hold
12,000
– – 0.08% 251
2023
Q3 		$819K Buy
+12,000
New +$1.02M 0.04% 419

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Garda Capital Partners's EXAS Position: Q4 2023 in Review

Garda Capital Partners sold out of Exact Sciences (EXAS) in Q4 2023, closing a stake of 10,591 shares — an estimated $694K sold.

Garda Capital Partners first reported a position in EXAS in Q3 2023 and held it in 1 quarter. The position peaked at $723K in Q3 2023. 648 funds tracked by Wall St. Rank hold EXAS as of Q4 2023.

  • Garda Capital Partners reported no remaining Exact Sciences position as of Q4 2023 after selling out during the quarter.
  • Garda Capital Partners sold 10,591 Exact Sciences shares in Q4 2023, an estimated $694K.
  • Garda Capital Partners first reported a position in Exact Sciences in Q3 2023 and held it in 1 quarter.
  • Garda Capital Partners's Exact Sciences position peaked at $723K in Q3 2023.
  • 648 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2023.

Based on Garda Capital Partners's 13F filing for Q4 2023, filed 12 Feb 2024.